GSK (LON:GSK) Shares Pass Above 200-Day Moving Average - Should You Sell?

GSK plc (LON:GSK - Get Free Report)'s stock price passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 1,421.59 ($19.08) and traded as high as GBX 1,495.50 ($20.07). GSK shares last traded at GBX 1,402.50 ($18.83), with a volume of 13,469,607 shares trading hands.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on the stock. Berenberg Bank reiterated a "hold" rating and issued a GBX 1,600 ($21.48) price objective on shares of GSK in a report on Friday. Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating and set a GBX 1,450 ($19.46) price objective on shares of GSK in a research report on Tuesday, July 8th. Shore Capital reaffirmed a "buy" rating and set a GBX 2,000 ($26.85) price objective on shares of GSK in a research report on Friday. Finally, JPMorgan Chase & Co. reaffirmed an "underweight" rating on shares of GSK in a research report on Friday.

GSK Price Performance

The stock has a market cap of £54.70 billion, a P/E ratio of 21.78, a PEG ratio of 1.24 and a beta of 0.31. The company has a debt-to-equity ratio of 114.64, a current ratio of 0.81 and a quick ratio of 0.73. The business's fifty day moving average price is GBX 1,435.32 and its 200 day moving average price is GBX 1,422.13.

GSK (LON:GSK - Get Free Report) last released its quarterly earnings data on Wednesday, April 30th. The company reported GBX 44.90 ($0.60) earnings per share (EPS) for the quarter. GSK had a return on equity of 18.08% and a net margin of 8.02%. Sell-side analysts forecast that GSK plc will post 175.980975 EPS for the current fiscal year.

Insider Buying and Selling at GSK

In other GSK news, insider Jonathan Symonds purchased 1,350 shares of the business's stock in a transaction on Friday, June 20th. The shares were purchased at an average cost of GBX 1,435 ($19.26) per share, for a total transaction of £19,372.50 ($26,003.36). Also, insider Emma Walmsley sold 5,473 shares of the stock in a transaction on Tuesday, May 6th. The stock was sold at an average price of GBX 1,449 ($19.45), for a total value of £79,303.77 ($106,448.01). In the last 90 days, insiders bought 1,905 shares of company stock valued at $2,732,835. 1.61% of the stock is currently owned by company insiders.

About GSK

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.